Toshio Ogihara is a Professor Emeritus of Osaka University Graduate School of Medicine, Suita, Japan. He is also the Director of the Osaka General Medical Center. His area of specialty is hypertension, renin-angiotensin system, genetics of hypertension, geriatric medicine, endocrinology, and gene therapy. He is the Chief Investigator of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial study, and he has published over 500 articles concerning hypertension, cardiovascular disease, diabetes mellitus, and geriatrics in international medical journals. In addition, he served on the Editorial Board of a number of scientific journals including Hypertension, Journal of Hypertension Circulation, and Circulation Research. Professor Ogihara is affiliated with numerous medical societies and associations. These included the International Society of Hypertension and the High Blood Pressure Council of the American Heart Association. He is a past Council Member (Vice President) of the International Society of Hypertension and was the President of the 21st Scientific Meeting in 2006 in Fukuoka. He also served as the President of the Japanese Society of Hypertension from 2004 to 2006.
Biography Updated on 10 August 2009